PAPER Lin AL, Rothman DL
SEARCH RESULTS
331202 RESULTS
PAPER Martande SS, Pradeep AR, Singh SP, Kumari M, Suke DK, Raju AP, Naik SB, Singh P, Guruprasad CN, Chatterji A
Periodontal health condition in patients with Alzheimer's disease.
Am J Alzheimers Dis Other Demen. 2014 Sep;29(6):498-502. PubMed: 25214647PAPER Li W, Yu J, Liu Y, Huang X, Abumaria N, Zhu Y, Huang X, Xiong W, Ren C, Liu XG, Chui D, Liu G
Elevation of brain magnesium prevents synaptic loss and reverses cognitive deficits in Alzheimer's disease mouse model.
Mol Brain. 2014 Sep 13;7:65. PubMed: 25213836PAPER Riverol M, Becker JT, López OL, Raji CA, Thompson PM, Carmichael OT, Gach HM, Longstreth WT Jr, Fried L, Tracy RP, Kuller LH
Relationship between Systemic and Cerebral Vascular Disease and Brain Structure Integrity in Normal Elderly Individuals.
J Alzheimers Dis. 2015;44(1):319-28. PubMed: 25213770PAPER van Buchem MA, Biessels GJ, Brunner la Rocca HP, de Craen AJ, van der Flier WM, Ikram MA, Kappelle LJ, Koudstaal PJ, Mooijaart SP, Niessen W, van Oostenbrugge R, de Roos A, van Rossum AC, Daemen MJ
The heart-brain connection: a multidisciplinary approach targeting a missing link in the pathophysiology of vascular cognitive impairment.
J Alzheimers Dis. 2014;42 Suppl 4:S443-51. PubMed: 25213769PAPER Wattmo C, Londos E, Minthon L
Response to cholinesterase inhibitors affects lifespan in Alzheimer's disease.
BMC Neurol. 2014 Sep 10;14:173. PubMed: 25213579PAPER Yan S, Li Z, Li H, Arancio O, Zhang W
Notoginsenoside R1 increases neuronal excitability and ameliorates synaptic and memory dysfunction following amyloid elevation.
Sci Rep. 2014 Sep 12;4:6352. PubMed: 25213453PAPER Jain S, Rathod V, Prajapati R, Nandekar PP, Sangamwar AT
Pregnane X Receptor and P-glycoprotein: a connexion for Alzheimer's disease management.
Mol Divers. 2014 Nov;18(4):895-909. Epub 2014 Sep 12 PubMed: 25213397PAPER Landel V, Baranger K, Virard I, Loriod B, Khrestchatisky M, Rivera S, Benech P, Féron F
Temporal gene profiling of the 5XFAD transgenic mouse model highlights the importance of microglial activation in Alzheimer's disease.
Mol Neurodegener. 2014 Sep 11;9:33. PubMed: 25213090PAPER Li H, Lv C, Zhang T, Chen K, Chen C, Gai G, Hu L, Wang Y, Zhang Z
Trajectories of age-related cognitive decline and potential associated factors of cognitive function in senior citizens of Beijing.
Curr Alzheimer Res. 2014;11(8):806-16. PubMed: 25212920PAPER Nascimento CM, Pereira JR, de Andrade LP, Garuffi M, Talib LL, Forlenza OV, Cancela JM, Cominetti MR, Stella F
Physical exercise in MCI elderly promotes reduction of pro-inflammatory cytokines and improvements on cognition and BDNF peripheral levels.
Curr Alzheimer Res. 2014;11(8):799-805. PubMed: 25212919PAPER Guimaraes HC, Fialho PP, Carvalho VA, Machado TH, Santos EL, Caramelli P
Apathy is not associated with performance in brief executive tests in patients with mild cognitive impairment and mild Alzheimer's disease.
Curr Alzheimer Res. 2014;11(8):792-8. PubMed: 25212918PAPER Zoller AS, Gaal IM, Royer CA, Locascio JJ, Amariglio RE, Blacker D, Okereke OI, Johnson KA, Sperling RA, Rentz DM, Marshall GA
SIST-M-IR activities of daily living items that best discriminate clinically normal elderly from those with mild cognitive impairment.
Curr Alzheimer Res. 2014;11(8):785-91. PubMed: 25212917PAPER Albert M, Soldan A, Gottesman R, McKhann G, Sacktor N, Farrington L, Grega M, Turner R, Lu Y, Li S, Wang MC, Selnes O
Cognitive changes preceding clinical symptom onset of mild cognitive impairment and relationship to ApoE genotype.
Curr Alzheimer Res. 2014;11(8):773-84. PubMed: 25212916PAPER Wakefield SJ, McGeown WJ, Shanks MF, Venneri A
Differentiating normal from pathological brain ageing using standard neuropsychological tests.
Curr Alzheimer Res. 2014;11(8):765-72. PubMed: 25212915Current Filters
No filters selected